Us Congress 2025-2026 Regular Session

Us Congress House Bill HB780

Introduced
1/28/25  

Caption

Alexandra’s Law Act of 2025

Impact

If enacted, HB 780 will modify existing legal frameworks surrounding drug-related offenses by introducing new liabilities for individuals who sell or distribute drugs linked to fatalities. Specifically, individuals found guilty under this act could be charged with homicide if their actions resulted in death, thus reinforcing accountability for behaviors that perpetuate the opioid crisis. This law aims to heighten awareness of the dangers posed by fentanyl, align judicial responses with public health initiatives, and potentially serve as a deterrent against drug distribution practices that may lead to overdose deaths.

Summary

House Bill 780, known as the 'Alexandra’s Law Act of 2025', seeks to address the severe threats posed by illicit drugs, particularly those laced with fentanyl. The bill amends the Controlled Substances Act to empower courts to issue advisory statements to individuals convicted of drug offenses where death has occurred due to drug use. It emphasizes the grave dangers associated with selling or administering such substances, especially when they are unknowingly mixed with fentanyl or its analogues, which can be life-threatening even in minor doses. Under this law, offenders would be explicitly warned of the lethal potential of these substances during sentencing.

Contention

Despite its well-intentioned goals, the bill may generate contention within communities and among lawmakers concerned about the potential implications of increasing legal penalties for drug-related offenses. Critics may argue that such measures could disproportionately affect marginalized groups and may not address the root causes of drug addiction, such as mental health issues or inadequate access to rehabilitation services. Discussions surrounding HB 780 may include debates about the effectiveness of punitive measures versus supportive interventions in dealing with drug-related crises.

Congress_id

119-HR-780

Policy_area

Crime and Law Enforcement

Introduced_date

2025-01-28

Companion Bills

No companion bills found.

Previously Filed As

US HB6671

Alexandra’s Law Act of 2023

US HB3215

Fentanyl Trafficker Elimination Act

US SB380

Felony Murder for Deadly Fentanyl Distribution Act of 2023

US HB916

Felony Murder for Deadly Fentanyl Distribution Act of 2023

US HB335

Standardizing Thresholds Of Penalties for Fentanyl Act or the STOP Fentanyl Act This bill reduces the drug quantity thresholds that trigger a mandatory minimum prison term for a defendant who manufactures, distributes, imports, exports, or possesses with intent to distribute fentanyl. The bill also creates enhanced criminal penalties for certain violations involving fentanyl that was imported along the U.S.-Mexico border. Specifically, the bill reduces from 400 to 5 grams the fentanyl quantity and from 100 to 0.05 grams the fentanyl analogue quantity that trigger a mandatory minimum prison term for high-level first-time or repeat offenders. It also reduces from 40 to 0.5 grams the fentanyl quantity and from 10 to 0.005 grams the fentanyl analogue quantity that trigger a mandatory minimum prison term for low-level first-time or repeat offenders. Additionally, the bill creates enhanced mandatory minimum prison terms for importing or exporting fentanyl that was imported along the U.S.-Mexico border.

US HB1291

Stopping Overdoses of Fentanyl Analogues Act

US HB467

Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.

US HB8701

Intelligence Reform and Transnational Crime Prevention Act of 2024

US HB3244

Stop Fentanyl Money Laundering Act of 2023

US HB10515

Health Extensions and Other Matters Act, 2025 Further Continuing Appropriations Act, 2025 Disaster Relief Supplemental Appropriations Act, 2025

Similar Bills

No similar bills found.